{"title": "Novartis drug Ilaris\u00ae approved by FDA to treat active systemic juvenile idiopathic arthritis, a serious form of childhood arthritis", "author": "Jennifer Levin", "url": "https://www.fiercepharma.com/pharma/novartis-drug-ilaris%C2%AE-approved-by-fda-to-treat-active-systemic-juvenile-idiopathic-arthritis", "hostname": "fiercepharma.com", "description": "Novartis drug Ilaris\u00ae approved by FDA to treat active systemic juvenile idiopathic arthritis, a serious form of childhood arthritis Ilaris\u00ae (canakinumab) is the first interleukin-1 beta... | Novartis drug Ilaris\u00ae approved by FDA to treat active systemic juvenile idiopathic arthritis, a serious form of childhood arthritis Ilaris\u00ae (canakinumab) is the first interleukin-1 beta...", "sitename": "FiercePharma", "date": "2013-05-10", "cleaned_text": "Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us Pharma Vaccines Asia Cell & Gene Therapy Drug Delivery Executives Manufacturing Facilities Recalls Warning Letters Marketing Special Reports Fierce 50 Resources Podcasts Fierce Events Industry Events Webinars Whitepapers Survey Events Subscribe Subscribe Pharma Vaccines Asia Cell & Gene Therapy Drug Delivery Executives Manufacturing Facilities Recalls Warning Letters Marketing Special Reports Fierce 50 Resources Podcasts Fierce Events Industry Events Webinars Whitepapers Survey Events Subscribe Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us "}